RecruitingNCT06161701

Steroid Diabetes in Patients With Kidney Disease

A Study on the Influencing Factors of Glucocorticoid Induced Elevated Blood Glucose in Nephrotic Patients

Sponsor

Zhejiang Provincial People's Hospital

Enrollment

300 participants

Start Date

Jan 10, 2024

Study Type

OBSERVATIONAL

Conditions

Nephrotic Syndrome

Summary

If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria2

Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus；
Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone；

Exclusion Criteria6

Patients with diabetes；
Those who are unable to communicate through language；
Uremic patients；
Unable to perform blood glucose monitoring and follow-up as required；
Those who have used glucocorticoids within the past 3 months and have accumulated a dose of 10mg or more of prednisone；
Participated in other clinical studies。

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERno intervention

no intervention

Locations(1)

Zhejiang provincial people's hospital

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06161701

Related Trials

Immune System Related Kidney Disease

NCT000019791 location

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

NCT075619572 locations